360 related articles for article (PubMed ID: 15182216)
1. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention.
Chelliah A; Burge MR
Drugs Aging; 2004; 21(8):511-30. PubMed ID: 15182216
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced disorders of glucose metabolism. Mechanisms and management.
Chan JC; Cockram CS; Critchley JA
Drug Saf; 1996 Aug; 15(2):135-57. PubMed ID: 8884164
[TBL] [Abstract][Full Text] [Related]
3. Avoiding hypoglycaemia: a new target of care for elderly diabetic patients.
Wong CW
Hong Kong Med J; 2015 Oct; 21(5):444-54. PubMed ID: 26044870
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.
Herings RM; de Boer A; Stricker BH; Leufkens HG; Porsius A
Lancet; 1995 May; 345(8959):1195-8. PubMed ID: 7739305
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.
Frier BM
Nat Rev Endocrinol; 2014 Dec; 10(12):711-22. PubMed ID: 25287289
[TBL] [Abstract][Full Text] [Related]
6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
7. Role of vildagliptin in managing type 2 diabetes mellitus in the elderly.
Halimi S; Raccah D; Schweizer A; Dejager S
Curr Med Res Opin; 2010 Jul; 26(7):1647-56. PubMed ID: 20441397
[TBL] [Abstract][Full Text] [Related]
8. Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy.
Barnett AH
Curr Med Res Opin; 2010 Jun; 26(6):1333-42. PubMed ID: 20370379
[TBL] [Abstract][Full Text] [Related]
9. Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents.
Barnett AH; Brice R; Hanif W; James J; Langerman H
Curr Med Res Opin; 2013 Nov; 29(11):1503-13. PubMed ID: 23952328
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced hypoglycaemia in type 2 diabetes.
Inkster B; Zammitt NN; Frier BM
Expert Opin Drug Saf; 2012 Jul; 11(4):597-614. PubMed ID: 22690846
[TBL] [Abstract][Full Text] [Related]
11. Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors.
Pedersen-Bjergaard U
Dan Med Bull; 2009 Nov; 56(4):193-207. PubMed ID: 19939337
[TBL] [Abstract][Full Text] [Related]
12. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors.
Mathieu C; Bollaerts K
Int J Clin Pract Suppl; 2007 Aug; (154):29-37. PubMed ID: 17593275
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycaemia as a barrier to improved glycaemic control.
Davidson JA
Int J Clin Pract Suppl; 2000 Sep; (112):57-62. PubMed ID: 11064953
[No Abstract] [Full Text] [Related]
14. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.
Rondags SM; de Wit M; Snoek FJ
Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919
[TBL] [Abstract][Full Text] [Related]
15. Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.
Owens DR; Bolli GB; Charbonnel B; Haak T; Landgraf W; Porcellati F; Traylor L; Kautzky-Willer A
Diabetes Obes Metab; 2017 Nov; 19(11):1546-1554. PubMed ID: 28449412
[TBL] [Abstract][Full Text] [Related]
16. Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?
Mathur S; Zammitt NN; Frier BM
Drug Saf; 2015 Jan; 38(1):17-32. PubMed ID: 25481812
[TBL] [Abstract][Full Text] [Related]
17. Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.
Thamer M; Ray NF; Taylor T
Clin Ther; 1999 Aug; 21(8):1387-400. PubMed ID: 10485510
[TBL] [Abstract][Full Text] [Related]
18. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older.
Greco D; Pisciotta M; Gambina F; Maggio F
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):215-9. PubMed ID: 20072965
[TBL] [Abstract][Full Text] [Related]
19. Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.
Holstein A; Egberts EH
Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):405-14. PubMed ID: 14614647
[TBL] [Abstract][Full Text] [Related]
20. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
Noh RM; Graveling AJ; Frier BM
Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
